Current Cancer Drug Targets

Papers
(The median citation count of Current Cancer Drug Targets is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Old and New Approaches to Target the Hsp90 Chaperone101
Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation84
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer77
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide31
Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects24
The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance21
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy20
Effects of Intermittent Hypoxia on Expression of Glucose Metabolism Genes in MCF7 Breast Cancer Cell Line20
Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy20
CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis19
The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer19
Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy19
Protectors of the Mitochondrial Permeability Transition Pore Activated by Iron and Doxorubicin17
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks16
Exosome as a Natural Gene Delivery Vector for Cancer Treatment14
Targeting IDH Mutations in AML: Wielding the Double-edged Sword of Differentiation14
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer14
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors14
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy14
Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer13
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors13
Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway12
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent11
Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy11
circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma11
Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma11
Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review11
Tumor Penetrating Peptide-Functionalized Tenascin-C Antibody for Glioblastoma Targeting11
PPARγ Agonists in Combination Cancer Therapies11
Cross Talk between COVID-19 and Breast Cancer10
Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications10
CDK9: Therapeutic Perspective in HCC Therapy10
Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer10
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)10
FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects10
Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT10
Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery Process9
Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs- TRAIL) Increases Antitumor Efficacy of Their Secretome9
Antibody-drug Conjugate Targets, Drugs, and Linkers9
The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review9
HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab9
Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling9
Flavonoids Overcome Drug Resistance to Cancer Chemotherapy by Epigenetically Modulating Multiple Mechanisms9
Tyrosine Kinase Inhibitors (TKIs) in Lung Cancer Treatment: A Comprehensive Analysis8
Idronoxil as an Anticancer Agent: Activity and Mechanisms8
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma8
MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX18
Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt8
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial8
The Evolving AML Genomic Landscape: Therapeutic Implications8
Molecular Dynamics in Esophageal Adenocarcinoma: Who’s in Control?8
The Roles of Alternative Splicing in Tumor-immune Cell Interactions8
Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells8
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study8
A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer8
β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer8
LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy7
Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer7
Peroxisome Proliferator-activated Receptor Gamma Coactivator-1 Alpha: A Double-edged Sword in Prostate Cancer7
Effects of Iron Chelation in Osteosarcoma7
Pharmacological Targeting of Ferroptosis in Cancer Treatment7
ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma7
Targeting MUC15 Protein in Cancer: Molecular Mechanisms and Therapeutic Perspectives6
Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study6
Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues6
A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer6
Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma6
Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma6
Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways6
Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer6
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators6
Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling6
Mesenchymal Epithelial Transition (MET): A Key Player in Chemotherapy Resistance and an Emerging Target for Potentiating Cancer Immunotherapy6
New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles6
Modulation of Matrix Metalloproteinases by Plant-derived Products6
Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism6
MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer5
Assessing Long Non-coding RNAs in Tobacco-associated Oral Cancer5
Role of Exosomes in Breast Cancer Management: Evidence-Based Review5
Resistance of Lenvatinib in Hepatocellular Carcinoma5
Inhibitors and Activators of the p38 Mitogen-Activated MAP Kinase (MAPK) Family as Drugs to Treat Cancer and Inflammation5
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention5
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells5
The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells5
Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy5
ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments5
Current Treatment and Future Trends of Immunotherapy in Breast Cancer5
Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling5
Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development5
USP48 Sustains Chemoresistance and Metastasis in Ovarian Cancer5
Cholangiocarcinoma Therapeutics: An Update5
Spleen Glucose Metabolism on [18F]-FDG PET/CT for Cancer Drug Discovery and Development cannot be Overlooked5
Modulation of ATP8B1 Gene Expression in Colorectal Cancer Cells Suggest its Role as a Tumor Suppressor5
PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors5
Metastatic Breast Cancer, Organotropism and Therapeutics: A Review5
Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer5
Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer5
Fas Ligand Enhances Apoptosis of Human Lung Cancer Cells Cotreated with RIG-I-like Receptor Agonist and Radiation5
PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance4
Immune Checkpoint Inhibitors in AML-A New Frontier4
Vaccine and Cell-based Therapeutic Approaches in Acute Myeloid Leukemia4
The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma4
Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism4
Durable Disease-free Survival in a Patient with Metastatic Triple-negative Breast Cancer Treated with Olaparib Monotherapy4
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC4
Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-based Drugs?4
Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics4
Hepatitis C Virus Infection and Treatment as Independent Prognostic Factors in Diffuse Large B-Cell Lymphoma Egyptian Patients4
The Therapeutic Potential of MEK1/2 Inhibitors in the Treatment of Gynecological Cancers: Rational Strategies and Recent Progress4
mRNA Vaccine - A New Cancer Treatment Strategy4
The Long Non-coding RNA Cytoskeleton Regulator (CYTOR) Sponges microRNA- 206 (miR-206) to Promote Proliferation and Invasion of HP75 Cells4
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression4
Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients4
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer Types4
Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer4
State-of-the-Art: Exosomes in Colorectal Cancer4
The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future4
Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib4
HIF-1α/Malat1/miR-141 Axis Activates Autophagy to Increase Proliferation, Migration, and Invasion in Triple-negative Breast Cancer4
VS-5584 Inhibits Human Osteosarcoma Cells Growth by Induction of G1- phase Arrest through Regulating PI3K/mTOR and MAPK Pathways4
Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells4
Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer4
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediated AKT /JNK and p53 Signaling Pathway4
miRNA as Regulators of Prostate Carcinogenesis and Endocrine and Chemoresistance4
The Interactions among Hypertension, Cancer, and COVID-19: Perspective with Regard to Ca2+/cAMP Signalling3
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis3
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications3
Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B13
Autophagy in Cancer Cell Transformation: A Potential Novel Therapeutic Strategy3
The Therapeutic Potential of Targeting Autophagy in the Treatment of Cancer3
The Current and Evolving Role of Immunotherapy in Metastatic Colorectal Cancer3
Potential Therapeutic Strategies for Targeting Y-Box-Binding Protein 1 in Cancers3
BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway3
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies3
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling3
Forkhead-box A3 (FOXA3) Represses Cancer Stemness and Partially Potentiates Chemosensitivity by Targeting Metastasis-Associated in Colon Cancer 1 (MACC1) Signaling Pathway in Colorectal Cancer Cells3
Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets3
Drug-Induced Peripheral Neuropathy: Diagnosis and Management3
Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin3
Regulation of Breast Cancer Progression by Noncoding RNAs3
Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma3
CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia3
The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis3
Pharmacological Inhibition of Exosome Machinery: An Emerging Prospect in Cancer Therapeutics3
Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis3
Targeting the HIF-1α/Cav-1 Pathway with a Chicory Extract/Daidzein Combination Plays a Potential Role in Retarding Hepatocellular Carcinoma3
Probiotics as a Therapeutic Approach in Colorectal Cancer3
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers3
Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric Cancer3
Synthesis and Cytotoxic Activity of Azine Derivatives of 6-Hydroxyxanthanodiene3
Lycopene as a Potential Bioactive Compound: Chemistry, Extraction, and Anticancer Prospective3
TROP2 Down-regulated DSG2 to Promote Gastric Cancer Cell Invasion and Migration by EGFR/AKT and DSG2/PG/β-Catenin Pathways3
Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment3
NONO-TFE3 Fusion Promotes Aerobic Glycolysis and Angiogenesis by Targeting HIF1A in NONO-TFE3 Translocation Renal Cell Carcinoma3
The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer3
Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway3
Inorganic Phosphate (Pi) in the Breast Cancer Microenvironment: Production, Transport and Signal Transduction as Potential Targets for Anticancer Strategies3
Advancement and Strategies for the Development of Peptide-drug Conjugates: Pharmacokinetic Modulation, Role and Clinical Evidence against Cancer Management2
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway2
Prognostic Value of MiRNAs in Patients with Laryngeal Cancer: A Systematic Review and Meta-Analysis2
Targeting NUPR1 for Cancer Treatment: A Risky Endeavor2
An Overview of CDK Enzyme Inhibitors in Cancer Therapy2
Dextran Sulfate Inhibits Angiogenesis and Invasion of Gastric Cancer by Interfering with M2-type Macrophages Polarization2
Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis2
Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis2
Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer2
Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin2
cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer2
Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development2
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma2
MALAT1 as a Versatile Regulator of Cancer: Overview of the Updates from Predatory Role as Competitive Endogenous RNA to Mechanistic Insights2
Anti-Obesity Medications in Cancer Therapy: A Comprehensive Insight2
Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma2
Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development2
Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8+ T Cells2
Salivary Protein Biomarkers for Diagnosis of Oral Squamous Cell Carcinoma2
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer2
Pathological Implications of Mucin Signaling in Metastasis2
HDAC4-mediated Deacetylation of Glutaminase Facilitates Glioma Stemness2
Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway2
Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells2
Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy2
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice2
The Role of Oxidative Stress in the Development and Therapeutic Intervention of Hepatocellular Carcinoma2
The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound2
FA-HA-Amygdalin@Fe2O3 and/or γ-Rays Affecting SIRT1 Regulation of YAP/TAZ-p53 Signaling and Modulates Tumorigenicity of MDA-MB231 or MCF-7 Cancer Cells2
Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers2
Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target2
Saikosaponin B4 Suppression Cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon Cancer2
Characteristic Hallmarks of Aging and the Impact on Carcinogenesis2
Mitochondrial Calcium Uniporter (MCU) that Modulates Mitochondrial Calcium Uptake and Facilitates Endometrial Cancer Progression through Interaction with VDAC11
Targeted Biological Effect of An Affitoxin Composed of an HPV16E7 Affibody Fused with Granzyme B (ZHPV16E7-GrB) Against Cervical Cancer In vitro and In vivo1
The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer1
LINC00461 Knockdown Enhances the Effect of Ixazomib in Multiple Myeloma Cells1
Netupitant-palonosetron (NEPA) for Preventing Chemotherapy-induced Nausea and Vomiting: From Clinical Trials to Daily Practice1
Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity1
Aminopeptidases in Cancer, Biology and Prospects for Pharmacological Intervention1
Synthesis and Preliminary Evaluations of [18F]fluorinated Pyridine-2- carboxamide Derivatives for Targeting PD-L1 in Cancer1
An Overview of Promising Biomarkers in Cancer Screening and Detection1
The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy1
Modifications of Ribonucleases in Order to Enhance Cytotoxicity in Anticancer Therapy1
Combined Transarterial Chemoembolization with Microwave Ablation versus Microwave Alone for Treatment of Medium Sized Hepatocellular Carcinoma1
Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR11
Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities1
Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian Patients1
A Pan-cancer Analysis to Determine the Prognostic Analysis and Immune Infiltration of HSPA51
VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells1
Present and Future Prospects of the Anti-cancer Activities of Saikosaponins1
Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered Method of Immunotherapy for Cancer1
DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma1
Therapeutic Potential of Clostridium novyi-NT in Cancer: Current Knowledge and Future Perspectives1
Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy1
COL10A1 as a Prognostic Biomarker in Association with Immune Infiltration in Prostate Cancer1
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer1
In Vitro Investigation Demonstrates IGFR/VEGFR Receptor Cross Talk and Potential of Combined Inhibition in Pediatric Central Nervous System Atypical Teratoid Rhabdoid Tumors1
Dextran Sulfate Inhibits Cell Proliferation and Induces Apoptosis by Regulating EZH2 in Gastric Carcinoma1
Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors1
Protein Arginine Methyltransferases 5 (PRMT5) affect Multiple Stages of Autophagy and Modulate Autophagy-related Genes in Controlling Breast Cancer Tumorigenesis1
Polyphyllin VII as a Potential Drug for Targeting Stemness in Hepatocellular Cancer via STAT3 Signaling1
The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review1
The Epigenetic Factors that Drive Cancer Drug Resistance1
Geiparvarin Inhibits the Progression of Osteosarcoma by Down-regulating COX2 Expression1
BZW2, CDT1 and IVD Act As Biomarkers for Predicting Hepatocellular Carcinoma1
UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer1
Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy Combined a Tyrosine Kinase Inhibitor for Treatment of Large Hepatocellular Carcinoma1
Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction1
Study on Cellular Localization of Bin Toxin and its Apoptosis-inducing Effect on Human Nasopharyngeal Carcinoma Cells1
The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy1
Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis1
Experimental Determination of Cancer Drug Targets with Independent Mechanisms of Resistance1
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells1
Strategic Combination Therapies for Ovarian Cancer1
Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehyd1
Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription1
Promotion of Cervical Cancer Cell Proliferation by miR-130b Expression Level Changes and Inhibition of its Apoptosis by Targeting CDKN1A Gene1
Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma: Disrupting the Tumor-stromal Cross-talk, Next Hope on the Horizon?1
0.028510808944702